Required fields are marked with *

Verification code

Loviride

{PARAM:[Name]}()
Category Human immunodeficiency Virus (HIV)
CAS 147362-57-0
Description Loviride is an RNA-directed DNA polymerase inhibitor potentially for the treatment of HIV infection.
Quotation Now

Product Information

Synonyms R 89439; R-89439; alpha-APA; (+-)-2-(6-Acetyl-m-toluidino)-2-(2,6-dichlorophenyl)acetamide
IUPAC Name 2-(2-acetyl-5-methylanilino)-2-(2,6-dichlorophenyl)acetamide
Molecular Weight 351.23
Molecular Formula C17H16Cl2N2O2
Canonical SMILES CC1=CC(=C(C=C1)C(=O)C)NC(C2=C(C=CC=C2Cl)Cl)C(=O)N
InChI InChI=1S/C17H16Cl2N2O2/c1-9-6-7-11(10(2)22)14(8-9)21-16(17(20)23)15-12(18)4-3-5-13(15)19/h3-8,16,21H,1-2H3,(H2,20,23)
InChIKey CJPLEFFCVDQQFZ-UHFFFAOYSA-N
Boiling Point 550.3±50.0 °C at 760 mmHg
Melting Point 226.3°C
Flash Point 286.6°C
Purity 99%
Density 1.44 g/cm3
Solubility In vitro:
10 mM in DMSO
Appearance Light yellow to yellow (Solid)
Storage Store at -20°C
Complexity 436
Exact Mass 350.0588831
Index Of Refraction 1.637
In Vitro Loviride (0.01 µM) inhibits HIV-1(IIIB) replication in MT-4 cells, also inhibits HIV-2 and SIV, with EC50s of 85.5, 7.4 µM for HIV-2 (ROD), HIV-2 (EHO), and 11.4, 28.5, 57.0 µM for SIV (mac251), SIV (agm3), SIV (mndGB1), respectively.
PSA 73.18000
Target Reverse Transcriptase; HIV
Vapor Pressure 3.69E-12mmHg at 25°C
XLogP3-AA 4.4

TAKE YOUR NEXT STEPS

Get Started With Our Industry Experience And Client-Centric Focus!

Talk to Us

Copyright © 2024 BOC Sciences. All rights reserved.